BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38012454)

  • 1. Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
    Ducatel A; Trillaud H; Reizine E; Vilgrain V; Sempoux C; Schmidt-Kobbe S; Gouw ASH; de Haas RJ; Julien C; Paradis V; Blanc JF; Chiche L; Balabaud C; Bioulac-Sage P; Frulio N
    Eur Radiol; 2023 Nov; ():. PubMed ID: 38012454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 3. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas.
    Nault JC; Couchy G; Caruso S; Meunier L; Caruana L; Letouzé E; Rebouissou S; Paradis V; Calderaro J; Zucman-Rossi J
    Hepatology; 2018 Sep; 68(3):964-976. PubMed ID: 29572896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.
    Sala M; Gonzales D; Leste-Lasserre T; Dugot-Senant N; Paradis V; Di Tommaso S; Dupuy JW; Pitard V; Dourthe C; Sciarra A; Sempoux C; Ferrell LD; Clouston AD; Miller G; Yeh MM; Thung S; Gouw ASH; Quaglia A; Han J; Huan J; Fan C; Crawford J; Nakanuma Y; Harada K; le Bail B; Castain C; Frulio N; Trillaud H; Possenti L; Blanc JF; Chiche L; Laurent C; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
    Hepatol Commun; 2020 Jun; 4(6):809-824. PubMed ID: 32490318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review.
    De Vos N; Van der Meulen J; Van Der Linden M; Claes K; Candaele AS; Vanlander A; Troisi RI; Van Vlierberghe H; Smeets P; Van Dorpe J; Hoorens A
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101478. PubMed ID: 32620388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
    Jiao J; Finberg KE; Jain D; Morotti R
    Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
    Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
    Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C
    Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
    Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.
    Frulio N; Balabaud C; Laurent C; Trillaud H; Bioulac-Sage P
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):e63-e67. PubMed ID: 31047837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
    Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
    AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.